As of 2025-05-08, the Relative Valuation of Arcadia Biosciences Inc (RKDA) is (53.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.39 USD, the upside of Arcadia Biosciences Inc based on Relative Valuation is -1314.1%.
The range of the Relative Valuation is (58.67) - (53.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 13.4x | 13.0x |
| Forward P/E multiples | 5.3x - 10.4x | 7.8x |
| Fair Price | (58.67) - (53.22) | (53.30) |
| Upside | -1436.4% - -1312.3% | -1314.1% |
| Date | P/E |
| 2025-05-05 | -0.75 |
| 2025-05-02 | -0.69 |
| 2025-05-01 | -0.70 |
| 2025-04-30 | -0.68 |
| 2025-04-29 | -0.65 |
| 2025-04-28 | -0.67 |
| 2025-04-25 | -0.67 |
| 2025-04-24 | -0.63 |
| 2025-04-23 | -0.58 |
| 2025-04-22 | -0.59 |
| 2025-04-21 | -0.56 |
| 2025-04-17 | -0.58 |
| 2025-04-16 | -0.62 |
| 2025-04-15 | -0.58 |
| 2025-04-14 | -0.61 |
| 2025-04-11 | -0.62 |
| 2025-04-10 | -0.58 |
| 2025-04-09 | -0.57 |
| 2025-04-08 | -0.53 |
| 2025-04-07 | -0.54 |
| 2025-04-04 | -0.53 |
| 2025-04-03 | -0.55 |
| 2025-04-02 | -0.52 |
| 2025-04-01 | -0.57 |
| 2025-03-31 | -0.58 |
| 2025-03-28 | -0.58 |
| 2025-03-27 | -0.66 |
| 2025-03-26 | -0.64 |
| 2025-03-25 | -0.67 |
| 2025-03-24 | -0.61 |
| 2025-03-21 | -0.61 |
| 2025-03-20 | -0.64 |
| 2025-03-19 | -0.67 |
| 2025-03-18 | -0.64 |
| 2025-03-17 | -0.63 |
| 2025-03-14 | -0.63 |
| 2025-03-13 | -0.63 |
| 2025-03-12 | -0.65 |
| 2025-03-11 | -0.63 |
| 2025-03-10 | -0.63 |
| 2025-03-07 | -0.66 |
| 2025-03-06 | -0.68 |
| 2025-03-05 | -0.75 |
| 2025-03-04 | -0.75 |
| 2025-03-03 | -0.74 |
| 2025-02-28 | -0.76 |
| 2025-02-27 | -0.75 |
| 2025-02-26 | -0.74 |
| 2025-02-25 | -0.71 |
| 2025-02-24 | -0.76 |